Want to read Slashdot from your mobile device? Point it at m.slashdot.org and keep reading!

 



Forgot your password?
typodupeerror
×
Medicine

India To Get 100 Million Astra Vaccine Shots by Next Month (bloomberg.com) 49

The world's largest vaccine maker is ramping up production of AstraZeneca Plc's Covid-19 shot, aiming to have 100 million doses ready by December for an inoculation drive that could begin across India that same month. From a report: If final-stage trial data show AstraZeneca's candidate gives effective protection from the virus, the Serum Institute of India -- which is partnered to produce at least one billion doses -- may get emergency authorization from New Delhi by December, said Adar Poonawalla, chief executive officer of the family-owned firm based in the western city of Pune. That initial amount will go to India, Poonawalla said in an interview on Thursday. Full approval early next year will allow distribution on a 50-50 basis with the South Asian nation and Covax, the World Health Organization-backed body that's purchasing shots for poor nations. Serum, which has tied up with five developers, has so far made 40 million doses of AstraZeneca's vaccine in the past two months and aims to start manufacturing Novavax's contender soon.
This discussion has been archived. No new comments can be posted.

India To Get 100 Million Astra Vaccine Shots by Next Month

Comments Filter:
  • by AlanObject ( 3603453 ) on Friday November 13, 2020 @11:06AM (#60719820)

    Given India's population and density, how much of a difference is 100 million immunizations going to do?

    Of course I realize they aren't planning to stop there, but it is going to take a long time at that rate to get coverage sufficient to stop the spread of the virus.

    Still, I hope they keep good records. It will be very interesting to see the outcome statistics.

    • 100 million in December to vaccine health workers and then some vulnerable/old people can make a big difference yes

    • by satsuke ( 263225 )

      That's where an epidemiologist would be useful.

      My take, 100M into a population of 1.3B is ~7.7%

      By now we know in what circumstances people more likely to become exposed and/or spread the virus, including asymptomatic carriers.

      So you'd think that vaccinating people in those groups would have an outsize effect on infections given the time in question.

      So .. healthcare workers, retail workers, people in group housing, factory workers that can't distance would be where I'd start.

      This is all an area where the US

      • Re: (Score:2, Insightful)

        by AlanObject ( 3603453 )

        That's where an epidemiologist would be useful.

        Yes indeed. Too many people take an incredibly simplistic view of vaccines. It's like oh, boy the vaccine! no more 'rona!

        What I am looking for is:

        At what rate does the vaccine stop new infections?

        At what rate does the vaccine stop symptoms among those who are already infected?

        What percentage of those vaccinated who had been infection still retain the virus and are capable of transmitting it?

        And, of course, what rate of serious side effects occur. For the record I don't consider fever and mus

      • The strategy of vaccinating older people will lower the death rate pretty fast.
    • by hey! ( 33014 )

      It's going to immunize the wealthy.

      • by rtb61 ( 674572 )

        The west is paying and they think those countries are way over populated, it all seems really odd and completely opposite to the reality of wars for profit in brown skin people countries. Now they want to save them, when they were happy to blow them up. It looks extremely suspect, that the third world gets it first, after the first world pays for it, when the first world consider the third world to be grossly overpopulated. All really, really odd. Generosity does not feature in well with exposed blatant war

      • by satsuke ( 263225 )

        I don't really fault countries for putting their national interests ahead of other nations.

        In a "one world government" or Star Trek Federation scenario than absolutely, everyone should have equal access to vaccines, but that's not us.

    • While giving it to everyone is the best method, if that is not possible you can provide the limited supply in a smarter way.

      People who are in highest risks, people who jobs is in contact with people, people who need to move around different communities.

      If you are smart on who you give it to, you can have a lot of good from a limited supply.

  • will hit you like a truck. Not sure if it's just the media blowing it out of proportion or Pfizer being cautious though. But if the COVID vaccines make a significant portion sick we're not going to see much uptake.

    I'm also still nervous about how fast these vaccines are being pushed through. There's too much money on the line, not only from the drug companies but from the economy in general.

    That said it'll go to healthcare workers and the military first (the the Military getting it by mandate) so th
    • Why does the Corona vaccine have to express the viral proteins inside cells BTW? Both the mRNA and Adenovirus variants seem to do this. Most existing vaccines seem to just dump recombinant produced antigens (or inactivated virii) in the blood with some adjuvants and let the body figure it out ... why does that not work for Corona?

      • I am wondering the same thing - although the mRNA approach strikes me as a lot scarier than how Oxford/AstraZeneca are doing it.

      • by ceoyoyo ( 59147 )

        This type of vaccine is extremely flexible, because you use the body's cells as the protein factory. As a bonus, you duplicate what goes on in an actual infection more closely, without the risk of actual infection. You can print out the mRNA from a text file and either encapsulate it or install it in a virus carrier.

        Traditional killed, inactivated and weakened virus vaccines require you to handle large quantities of the actual virus. This makes research and production more complicated, and also carries the

        • I understand why the new approaches are attractive ... but there is comfort in the tried and true.

          There's a ton of experience with recombinant antigen vaccines out there. With all the money floating around labs could try a lot of different antigens in parallel and maybe leave the experimentation with mRNA/Ad5 for a time when you don't need to vaccinate such a large number of people in a rush? Is there any specific reason they would not work for Corona?

          • by ceoyoyo ( 59147 )

            Probably. Remember that the COVID-19 (SARS-2) vaccines didn't start from zero in February. They're modifications of SARS-1 and MERS vaccines that have been under development for a couple decades, so quite a bit of the hard work was already done, and the choices various companies have made are motivated by a lot of existing work. It's not a coincidence everyone is targeting the spike protein, for example, and the choice of target is very important for a successful vaccine.

            Here's an article by an actual medic

    • It's a risk all right, but over 1.3M people have been killed by the virus already. I hope people remember that if the vaccine has some harmful rare or delayed side effects.
    • There are rumors of trial participants being tired the next day etc, but well the participants don't know if they received the placebo or real thing so until the calculations are done nobody really knows what the side effects are and how common they are. Could easily be that half the side effect reporters actually received placebo, that's the kind of thing human brain does sometimes. The only word on effectiveness is also "over 90%" which is quite vague, so really, there is nothing to it but to wait for the
      • by Tablizer ( 95088 )

        My dog died of a placebo, you insensitive clod!

      • by ceoyoyo ( 59147 )

        "Over 90%" isn't vague. 90% indicates the lower bound of the confidence interval. The distribution is skewed so the upper bound is 100%. As more people in the trial get COVID the confidence interval will narrow.

        All of the current phase III trials were designed with planned assessments partway through. IIRC most or all of them were planned so if the vaccine was extremely effective (>90%) the first readout would be positive, then there would be additional reads for more conservative efficacies. The trials

  • >"India To Get 100 Million Astra Vaccine Shots"

    Can we PLEASE use the correct terms? They are not "shots", they are injections, of a vaccine, performed with a syringe. You were not shot with a shot using a shot. Shooting is something you do with a gun, arrow, or projectile. "Shot" is the past-tense of "shoot" (or the pellets expended by a shot gun).

    And the above should be "India To Get 100 Million Astra Vaccine Doses." It really isn't that difficult.

  • Though there is a vaccine, people should also wear the necessary safety equipment. It should be mandatory to wear a level 3 mask Canada [arrowsafetycanada.com]. For the affected area services, they should wear high-quality gowns. They should also follow the other precautions carefully.

Business is a good game -- lots of competition and minimum of rules. You keep score with money. -- Nolan Bushnell, founder of Atari

Working...